At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
CR crane
Trading 01-16 09:49:49 EST
207.09
+0.18
+0.08%
High207.36Low205.98Vol4.67K
Open205.98D1 Closing206.91Amplitude0.67%
Mkt Cap11.93BTradable Cap10.10BTotal Shares57.60M
T/O964.94KT/O Rate0.01%Tradable Shares48.76M
P/B--ROE--EPS0.00
52wk High--52wk Low--P/E--
Dividend--Div.Yield--ROA--

Loading ...

How Crane’s Q3 Beat And Operational Discipline At Crane (CR) Has Changed Its Investment Story
Simply Wall St.  ·  16:17
How Crane’s Q3 Beat And Operational Discipline At Crane (CR) Has Changed Its Investment Story
Antengene Presents at JPM: Strong Clinical Data Update and Strategic Focus on Next-Generation ADCs and TCEs
prnewswire  ·  09:00
Antengene Presents at JPM: Strong Clinical Data Update and Strategic Focus on Next-Generation ADCs and TCEs
Moleculin Accelerates Outlook Into 2026 With First Pivotal Trial Unblinding on Track, Global Trial Expansion, and Multiple Externally/IIT Funded Clinical Programs
GlobeNewswire  ·  01-12
Moleculin Accelerates Outlook Into 2026 With First Pivotal Trial Unblinding on Track, Global Trial Expansion, and Multiple Externally/IIT Funded Clinical Programs
Relmada Therapeutics Provides Regulatory Update Confirming FDA Alignment on Registrational Studies Design for NDV-01 for Two Separate Indications
GlobeNewswire  ·  01-12
Relmada Therapeutics Provides Regulatory Update Confirming FDA Alignment on Registrational Studies Design for NDV-01 for Two Separate Indications
Press Release: Syndax Reports Preliminary 2025 Financial Highlights and Provides Business Updates at the 44th Annual J.P. Morgan Healthcare Conference
Dow Jones  ·  01-12
Press Release: Syndax Reports Preliminary 2025 Financial Highlights and Provides Business Updates at the 44th Annual J.P. Morgan Healthcare Conference
BBOT Announces New Clinical Data Advancing Its Portfolio of Three Innovative and Differentiated RAS and PI3Kα Pipeline Programs
GlobeNewswire  ·  01-07
BBOT Announces New Clinical Data Advancing Its Portfolio of Three Innovative and Differentiated RAS and PI3Kα Pipeline Programs
CR CONSTRUCTION (01582): Winding-Up Order Against CR Sea Has Been Terminated
Stock News  ·  01-07
CR CONSTRUCTION (01582): Winding-Up Order Against CR Sea Has Been Terminated
Actuate Therapeutics Announces Positive Patient Outcomes from Phase 1 Trial in Difficult-to-Treat Refractory Pediatric Cancers
GlobeNewswire  ·  01-06
Actuate Therapeutics Announces Positive Patient Outcomes from Phase 1 Trial in Difficult-to-Treat Refractory Pediatric Cancers
NovaBridge Presents Positive Givastomig Dose Expansion Data from the Phase 1b Combination Study in Patients with 1L Metastatic Gastric Cancer
GlobeNewswire  ·  01-06
NovaBridge Presents Positive Givastomig Dose Expansion Data from the Phase 1b Combination Study in Patients with 1L Metastatic Gastric Cancer
BRIEF-Crane Company Completes Acquisition Of Precision Sensors & Instrumentation
Reuters  ·  01-05
BRIEF-Crane Company Completes Acquisition Of Precision Sensors & Instrumentation
Baker Hughes Closes Sale of Precision Sensors & Instrumentation to Crane Company
Reuters  ·  01-05
Baker Hughes Closes Sale of Precision Sensors & Instrumentation to Crane Company
Crane Company Publishes Update to Financial Calendar
Reuters  ·  01-05
Crane Company Publishes Update to Financial Calendar
Crane Company Completes Acquisition of Precision Sensors & Instrumentation and Announces Date for Fourth Quarter 2025 Earnings Release and Teleconference
THOMSON REUTERS  ·  01-05
Crane Company Completes Acquisition of Precision Sensors & Instrumentation and Announces Date for Fourth Quarter 2025 Earnings Release and Teleconference
Press Release: enGene Reports Full Year 2025 Financial Results and Provides Business Update
Dow Jones  ·  2025-12-23
Press Release: enGene Reports Full Year 2025 Financial Results and Provides Business Update
Abbisko Therapeutics’ CSF-1R Inhibitor Pimicotinib Approved by the China NMPA, Addressing the Treatment Gap for Tenosynovial Giant Cell Tumor
GlobeNewswire  ·  2025-12-22
Abbisko Therapeutics’ CSF-1R Inhibitor Pimicotinib Approved by the China NMPA, Addressing the Treatment Gap for Tenosynovial Giant Cell Tumor
CR Construction (01582): CR Sea to Strive for Termination Ruling at January 7, 2026 Hearing
Stock News  ·  2025-12-18
CR Construction (01582): CR Sea to Strive for Termination Ruling at January 7, 2026 Hearing
Why Is Gene Therapy Focused Senti Bio Stock Falling Today?
Benzinga_recent_news  ·  2025-12-10
Why Is Gene Therapy Focused Senti Bio Stock Falling Today?
Senti Bio Announces Updated SENTI-202 Clinical Data from Ongoing Phase 1 Trial in Relapsed or Refractory Acute Myeloid Leukemia Patients, Demonstrating Deep, MRD Negative, Durable Complete Remissions and a Favorable Safety Profile
GlobeNewswire  ·  2025-12-09
Senti Bio Announces Updated SENTI-202 Clinical Data from Ongoing Phase 1 Trial in Relapsed or Refractory Acute Myeloid Leukemia Patients, Demonstrating Deep, MRD Negative, Durable Complete Remissions and a Favorable Safety Profile
ASH 2025 | Ascentage Pharma Presents First Dataset from Phase III POLARIS-1 Study of Olverembatinib in Newly Diagnosed Ph+ ALL Shows a Best MRD-Negativity CR Rate Exceeding 60%
GlobeNewswire  ·  2025-12-09
ASH 2025 | Ascentage Pharma Presents First Dataset from Phase III POLARIS-1 Study of Olverembatinib in Newly Diagnosed Ph+ ALL Shows a Best MRD-Negativity CR Rate Exceeding 60%
Genmab Announces New Data from Phase 1b/2 EPCORE® CLL-1 Highlighting Potential of Epcoritamab as Monotherapy and in Combination for Patients with Richter Transformation (RT)
GlobeNewswire  ·  2025-12-09
Genmab Announces New Data from Phase 1b/2 EPCORE® CLL-1 Highlighting Potential of Epcoritamab as Monotherapy and in Combination for Patients with Richter Transformation (RT)

Introduction

Company Name.
crane
Affiliated Markets:
ARCA
Listing Date:
--
Main Business:
Crane NXT, Co. focuses on payment and merchandising technologies. It indents to offer electronic equipment and associated software leveraging extensive, and proprietary core capabilities, including payment verification and authentication, as well as automation solutions, field service solutions, remote diagnostics, and productivity enhancing software solutions. The company is based in Stamford, Connecticut.
Issue price:
--